Research-Grade Peptides | 99%+ Purity Verified | US Delivery 2–5 Days
Save 5% with Crypto
SaiyanMed

Your Cart

No products in the cart.

What Is KLOW Stack? Ingredients and Research Context

Schematic of four distinct KLOW components beside a cellular research context.

KLOW is the name for a four-component set of separate compounds: BPC-157, TB-500, GHK-Cu, and KPV. GHK-Cu is a copper–tripeptide complex, not free GHK or a copper salt. The same naming convention describes KLOW as GLOW plus KPV, with GLOW denoting the GHK-Cu, BPC-157, and TB-500 trio.[1]

Conceptual comparison of three GLOW components and the additional KPV component in KLOW.

KPV: Identity and Intestinal Signaling

Conceptual intestinal epithelial and immune-cell contexts for KPV research.

KPV is Lys-Pro-Val, the C-terminal tripeptide of alpha-melanocyte-stimulating hormone (alpha-MSH).[2] It is a fragment of the hormone, not a shortened GHK. In Caco2-BBE intestinal epithelial cells stimulated with IL-1beta, alpha-MSH did not alter the kinetics of I-kappaB-alpha degradation, while KPV reduced inflammatory signaling.[2]

KPV’s size places it in the substrate range of PepT1, a proton-coupled di/tripeptide transporter normally expressed in the small intestine and induced in inflamed colon.[2] Transport is not just delivery. In Caco2-BBE cells, KPV reduced IL-1beta-induced NF-kB activation, I-kappaB-alpha degradation, MAPK phosphorylation, and IL-8 output.[2] Both IL-8 mRNA and secreted IL-8 protein fell in those stimulated cultures.[2] The effect shortened the duration of NF-kB activation: less I-kappaB-alpha degradation occurred after stimulation, and baseline recovered earlier with KPV.[2] NF-kB and MAPK control inflammatory cytokine expression, while IL-8 links epithelial signaling to immune-cell recruitment.[2]

The transporter dependence was visible across cell lines. HT29-Cl.19A cells, which lack hPepT1, did not show the KPV-associated reduction in NF-kB-dependent luciferase activity; stable hPepT1 expression restored the response, and a competing PepT1 substrate reversed KPV’s effect in Caco2-BBE cells.[2] Caco2-BBE is a human intestinal epithelial line, while HT29-Cl.19A is a human colonic epithelial line. Caco2-BBE cells expressed MC3R and MC5R, but KPV did not raise intracellular cAMP, and the authors attributed the response to PepT1-mediated uptake rather than those receptors in that line.[2]

Jurkat cells add an immune-cell context. They are a human T-cell line, and they expressed functional hPepT1; KPV reduced TNF-alpha-induced I-kappaB-alpha degradation and IL-8 mRNA in that line.[2]

The animal work uses DSS- and TNBS-induced colitis in mice. KPV reduced weight loss, colonic myeloperoxidase activity, histological inflammation, and pro-inflammatory cytokine expression in those models.[2] The response reflected lower pro-inflammatory cytokine expression rather than higher IL-10 mRNA in colonic tissue.[2] In the DSS model, KPV also limited colon weight gain and shortening; TNBS-treated mice showed reduced colon shortening.[2] KPV alone did not alter basal myeloperoxidase activity or other inflammatory parameters in colonic mucosa.[2]

GHK-Cu: Copper Binding and Matrix Biology

GHK is the tripeptide Gly-His-Lys, with affinity for copper(II).[3] GHK-Cu is the peptide–copper complex, not free GHK and not a copper salt. In fibroblast cultures, GHK-Cu stimulated collagen synthesis independently of a change in cell number.[3] Increased collagen output was therefore not explained by more cells; the measurement is collagen synthesis in culture.

The copper chemistry is specific but condition-dependent. In neutral solution, GHK forms a mononuclear 1:1 Cu(II) complex, and the histidine imidazole ring contributes a coordinating nitrogen.[4] The 1:1 refers to one peptide per Cu(II) center, not a mass ratio between blend ingredients. The same solution work reports pH-dependent changes and notes that the solid-state polymeric structure with oxygen-bridged Cu(II) pairs does not exist in solution.[4] At elevated pH the Cu(II) structure changes while the bound imidazole is retained; the coordination environment is therefore not one fixed geometry for every preparation.[4]

In a rat experimental wound-chamber model, GHK-Cu increased dry weight, DNA, total protein, collagen, and glycosaminoglycan contents; type I and type III collagen mRNAs rose, while TGF-beta mRNA did not.[5] In the wound chambers DNA also rose, unlike the fibroblast cultures where collagen synthesis changed independently of cell number. Collagen synthesis was stimulated about twice as much as noncollagen protein synthesis, and dermatan sulfate increased.[5] A control tripeptide produced no significant effect, separating GHK-Cu’s activity from a generic tripeptide response in that model.[5] This is extracellular-matrix accumulation in an animal wound model, a different endpoint from collagen synthesis in isolated fibroblasts.

BPC-157: Tendon-Cell Findings

BPC-157 is a pentadecapeptide, meaning 15 amino acids; it is described as a partial sequence of body protection compound isolated from human gastric juice.[6] In rat Achilles-tendon explants, BPC-157 increased fibroblast outgrowth.[6] In cultured rat tendon fibroblasts, it increased survival under hydrogen-peroxide stress and produced dose-dependent migration, but did not directly increase proliferation in the MTT assay.[6] Explant outgrowth, migration, survival under stress, and the MTT proliferation result are separate endpoints. The explant assay measures cells leaving tendon tissue, not isolated-cell proliferation.

FAK and paxillin phosphorylation increased dose-dependently while total FAK and paxillin amounts were unchanged.[6] That indicates a change in activation state rather than more of those proteins. BPC-157 also induced F-actin formation and accelerated fibroblast spreading on culture dishes, consistent with cytoskeletal reorganization during migration.[6] The authors proposed FAK–paxillin activation as likely mediation of the migration and outgrowth effects.[6]

TB-500 and Thymosin Beta-4: Full-Length Peptide vs. Fragment

One analytical study identified Ac-LKKTETQ in the TB-500 material it tested.[7] That is a seven-residue internal segment corresponding to residues 17–23 of mature human thymosin beta-4, acetylated at the fragment’s own N-terminus.[7] It is not the parent protein’s N-terminal fragment, and the acetylation does not make it the full chain.

Mature human thymosin beta-4 is a 43-residue chain after removal of the initiator methionine; the 44-residue database entry includes that methionine, annotated as removed.[8] The intact protein binds and sequesters actin monomers, inhibiting actin polymerization.[8] Thymosin beta-4 and profilin are two major actin-monomer sequestering proteins: thymosin beta-4 prevents filament joining, while profilin:actin supports barbed-end elongation.[9] Structural work shows two thymosin beta-4 helices contacting the barbed and pointed faces of G-actin and preventing incorporation of the bound monomer into a filament.[9] That finding concerns the intact 43-residue chain, not the isolated seven-residue fragment. A second structure shows a more open nucleotide binding cleft on G-actin, with disruption of the Tbeta4 C-terminal helix interaction during profilin exchange; the exchange involves steric and allosteric components.[9] The authors relate profilin’s sensitivity to actin’s conformational state to profilin dissociation during filament elongation.[9]

Related research: What Is GLOW Stack? Ingredients and Peptide Composition; KLOW Stack.

For laboratory and analytical education only; research use only (RUO); not medical or veterinary advice, not a validated protocol, and not for human or animal administration.

References

  1. GLOW Peptide Blend: GHK-Cu, BPC-157, and TB-500, and How KLOW Differs
  2. PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation
  3. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+
  4. Structure of the Glycyl-L-histidyl-L-lysine–copper(II) complex in solution
  5. In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds
  6. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration
  7. Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential
  8. UniProtKB/Swiss-Prot P62328: Human thymosin beta-4
  9. Structural basis of thymosin-β4/profilin exchange leading to actin filament polymerization